tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Douglas Miehm, 25 are a HOLD (29.07%), 61 are a BUY (70.93%).
Analyst Douglas Miehm, currently employed at RBC, carries an average stock price target met ratio of 62.51% that have a potential upside of 19.83% achieved within 140 days.
Douglas Miehm’s has documented 169 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AUPH, Aurinia Pharmaceuticals at 07-Aug-2026.
Analyst best performing recommendations are on PCRX (PACIRA PHARMACEUTICALS).
The best stock recommendation documented was for BHC (BAUSCH HEALTH COMPANIES) at 5/5/2023. The price target of $8 was fulfilled within 13 days with a profit of $2.17 (37.22%) receiving and performance score of 28.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Aug-2026
$16
$0.17 (1.07%)
$15
1 months 28 days ago
(07-Aug-2026)
14/19 (73.68%)
$0.15 (0.95%)
213
Buy Since 06-Oct-2016
$16
$-1.23 (-7.14%)
$10
10 months 2 days ago
(03-Dec-2025)
7/9 (77.78%)
$1.09 (7.31%)
436
Hold Since 02-May-2024
$21
$3.77 (21.88%)
10 months 28 days ago
(07-Nov-2025)
2/4 (50%)
$6.39 (43.74%)
544
Buy Since 30-Jul-2025
$17
$-0.23 (-1.33%)
1 years 2 months 5 days ago
(30-Jul-2025)
1/1 (100%)
$7.95 (87.85%)
327
Buy Since 15-Feb-2024
$11
$-6.23 (-36.16%)
$11
1 years 3 months 5 days ago
(30-Jun-2025)
2/2 (100%)
$2.53 (29.87%)
286
Which stock is Douglas Miehm most bullish on?
Which stock is Douglas Miehm most reserved on?
What Year was the first public recommendation made by Douglas Miehm?
